Friedrich Haag - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Friedrich Haag

Showing results (141-150 of 143) with videos related to

Pageof 15

Sort By:

You have reached the last page of results.This site can display upto 143 results.

Theranostics|March 21, 2020

Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignanciesLevin Schriewer, Kerstin Schütze, Katharina Petry, et al.

Cell Death & Disease|April 20, 2026

Methodological guidelines for P2X receptor assays and data interpretationDariusz C Gorecki, Elena Adinolfi, Sahil Adriouch, et al.

Nature Communications|June 3, 2024

Generation of nanobodies from transgenic 'LamaMice' lacking an endogenous immunoglobulin repertoireThomas Eden, Alessa Z Schaffrath, Janusz Wesolowski, et al.

Pageof 15

Search research articles

Showing results (141-150 of 143) with videos related to

Sort By:

Pageof 15

You have reached the last page of results.This site can display upto 143 results.

Theranostics|March 21, 2020

Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignanciesLevin Schriewer, Kerstin Schütze, Katharina Petry, et al.

Cell Death & Disease|April 20, 2026

Methodological guidelines for P2X receptor assays and data interpretationDariusz C Gorecki, Elena Adinolfi, Sahil Adriouch, et al.

Nature Communications|June 3, 2024

Generation of nanobodies from transgenic 'LamaMice' lacking an endogenous immunoglobulin repertoireThomas Eden, Alessa Z Schaffrath, Janusz Wesolowski, et al.

Pageof 15